Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Clinical OutsourcingClinical Outsourcing
Not Confirmed
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Not Confirmed
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
03-06 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Clinical OutsourcingClinical Outsourcing
Industry Trade Show
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Industry Trade Show
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
03-06 March, 2026
Digital content

02 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/02/3247875/0/en/Invivyd-to-Host-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Corporate-Update-Conference-Call-on-March-5-2026.html

02 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/02/3247840/0/en/Invivyd-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

24 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/24/3243385/0/en/New-Publication-Demonstrates-Variant-Agnostic-Correlate-of-Protection-from-COVID-19-for-Invivyd-Monoclonal-Antibody-Useful-for-Understanding-of-and-Confidence-in-COVID-19-Antibodie.html

03 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/03/3230918/0/en/Invivyd-Aligns-with-the-U-S-FDA-on-LIBERTY-a-Phase-3-Trial-to-Evaluate-the-Safety-of-VYD2311-Antibody-Versus-mRNA-COVID-Vaccine-and-to-Characterize-the-Safety-and-Immunology-of-Ant.html

22 Jan 2026
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/invivyd-teams-olympic-skier-lindsey-vonn-antibody-education

20 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/20/3221569/0/en/Invivyd-and-SPEAR-Study-Group-Announce-Plan-for-Phase-2-Study-of-VYD2311-for-Treatment-of-Long-COVID-and-COVID-Vaccine-Injured-Individuals-to-Commence-Mid-2026.html
ABOUT THIS PAGE